• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者术前使用抗肥胖药物的体验以及与减重手术期望的关联。

Patients experience with preoperative use of anti-obesity medications and associations with bariatric surgery expectations.

作者信息

Samuels Jason M, Patel Mayur B, Roumie Christianne L, Self Wesley, Funk Luke, Spann Matthew D, Niswender Kevin D

机构信息

Section of Surgical Sciences, Division of General Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.

Department of Surgery, Veterans Administration Tennessee, Nashville, Tennessee.

出版信息

Surg Obes Relat Dis. 2025 Feb;21(2):109-114. doi: 10.1016/j.soard.2024.08.041. Epub 2024 Sep 14.

DOI:10.1016/j.soard.2024.08.041
PMID:39389849
Abstract

BACKGROUND

Few studies have investigated the use of anti-obesity medications (AOMs) before bariatric surgery and how prior use impacts patients' goals and expectations for surgery.

OBJECTIVES

This study investigated associations between patients' experiences with AOMs and weight loss expectations before bariatric surgery.

SETTINGS

Single tertiary university hospital.

METHODS

Patients were electronically surveyed with a 31-item questionnaire via email or the patient portal with a primary predictor variable of AOMs presurgery. Outcomes included degree of weight loss and weight regain and motivation for seeking surgery.

RESULTS

A total of 346 persons were invited to complete the survey; 112 surveys (32.4%) were completed, with 7 excluded because of not answering the AOM question. 73% reported AOM use. Among those who took AOMs before seeking bariatric surgery, average weight loss was 13 kg (SD 10) corresponding to a 4.4-kg/m decrease in BMI. Of past AOM recipients, 87% reported weight regain on stopping AOMs. Average weight regain was 18 kg (SD 13; 126% increase). Patients reported improved longevity and quality of life as motivation for seeking surgery, with AOM use history having no effect. Subjects reported an average weight loss goal of 65.8 kg (39% of baseline weight) from bariatric surgery.

CONCLUSIONS

AOMs were commonly used in those seeking bariatric surgery, but motivation for surgery did not differ by AOM use history. Motivations were most often related to goals for better overall health.

摘要

背景

很少有研究调查减肥手术前使用抗肥胖药物(AOMs)的情况,以及先前的使用如何影响患者对手术的目标和期望。

目的

本研究调查了减肥手术前患者使用AOMs的经历与体重减轻期望之间的关联。

地点

单一的三级大学医院。

方法

通过电子邮件或患者门户网站对患者进行电子问卷调查,问卷包含31个项目,主要预测变量为术前使用AOMs的情况。结果包括体重减轻程度、体重反弹情况以及寻求手术的动机。

结果

共邀请346人完成调查;112份问卷(32.4%)被完成,其中7份因未回答AOM问题而被排除。73%的人报告使用过AOMs。在寻求减肥手术前服用AOMs的患者中,平均体重减轻13千克(标准差10),相当于体重指数(BMI)下降4.4千克/米²。在过去使用过AOMs的患者中,87%的人报告停止使用AOMs后体重反弹。平均体重反弹18千克(标准差13;增加126%)。患者报告改善寿命和生活质量是寻求手术的动机,AOM使用史对此没有影响。受试者报告减肥手术的平均体重减轻目标为65.8千克(占基线体重的39%)。

结论

寻求减肥手术的患者中普遍使用AOMs,但手术动机不因AOM使用史而异。动机最常与改善整体健康的目标相关。

相似文献

1
Patients experience with preoperative use of anti-obesity medications and associations with bariatric surgery expectations.患者术前使用抗肥胖药物的体验以及与减重手术期望的关联。
Surg Obes Relat Dis. 2025 Feb;21(2):109-114. doi: 10.1016/j.soard.2024.08.041. Epub 2024 Sep 14.
2
Obesity Solutions for Patients over 65 Years of Age: Surgeon Perspectives on Anti-obesity Medications and Metabolic Bariatric Surgery - International Survey Study.65岁以上患者的肥胖解决方案:外科医生对减肥药物和代谢性减肥手术的看法——国际调查研究
Obes Surg. 2025 Jul 17. doi: 10.1007/s11695-025-08026-w.
3
Bariatric outcomes of high BMI patients with preoperative anti-obesity medications.术前使用抗肥胖药物的高体重指数患者的减肥手术效果
Surg Endosc. 2025 Jul 10. doi: 10.1007/s00464-025-11851-w.
4
Adverse event comparison between glucagon-like peptide-1 receptor agonists and other antiobesity medications following bariatric surgery.减重手术后胰高血糖素样肽-1 受体激动剂与其他减肥药的不良事件比较。
Diabetes Obes Metab. 2024 Sep;26(9):3906-3913. doi: 10.1111/dom.15737. Epub 2024 Jun 27.
5
Surgery for weight loss in adults.成人减肥手术。
Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
8
Tirzepatide and health-related quality of life in adults with obesity or overweight: Results from the SURMOUNT-3 phase 3 randomized trial.替尔泊肽与肥胖或超重成人的健康相关生活质量:SURMOUNT-3 三期随机试验结果
Diabetes Obes Metab. 2025 May 14. doi: 10.1111/dom.16463.
9
Effects of preoperative glucagon-like peptide-1 receptor agonist therapy on weight loss following bariatric surgery.术前胰高血糖素样肽-1受体激动剂治疗对减肥手术后体重减轻的影响。
Surg Endosc. 2025 Jun 9. doi: 10.1007/s00464-025-11838-7.
10
Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications.抗肥胖药物治疗停药后体重的变化轨迹。
BMC Med. 2025 Jul 22;23(1):398. doi: 10.1186/s12916-025-04200-0.

引用本文的文献

1
Reduced Risk of Cardiovascular Diseases After Bariatric Surgery Based on the New Predicting Risk of Cardiovascular Disease EVENTs Equations.基于新的心血管疾病事件风险预测方程,减重手术后心血管疾病风险降低
J Am Heart Assoc. 2025 Mar 18;14(6):e038191. doi: 10.1161/JAHA.124.038191. Epub 2025 Mar 7.

本文引用的文献

1
Efficacy of Intragastric Balloon versus Liraglutide as Bridge to Surgery in Super-Obese Patients.胃内球囊与利拉鲁肽作为超级肥胖患者手术桥接的疗效比较。
Obes Facts. 2023;16(5):457-464. doi: 10.1159/000531459. Epub 2023 Aug 14.
2
National trends in prescription drug expenditures and projections for 2023.2023年处方药支出的全国趋势及预测。
Am J Health Syst Pharm. 2023 Jul 7;80(14):899-913. doi: 10.1093/ajhp/zxad086.
3
Do reasons for undergoing bariatric surgery influence weight loss and health-related quality of life?-A Swedish mixed method study.
减重手术的原因是否会影响减重效果和与健康相关的生活质量?——一项瑞典混合方法研究。
PLoS One. 2022 Oct 10;17(10):e0275868. doi: 10.1371/journal.pone.0275868. eCollection 2022.
4
Women's Reasons to Seek Bariatric Surgery and Their Expectations on the Surgery Outcome - a Multicenter Study from Five European Countries.女性寻求减肥手术的原因及其对手术结果的期望——来自五个欧洲国家的多中心研究。
Obes Surg. 2022 Nov;32(11):3722-3731. doi: 10.1007/s11695-022-06280-w. Epub 2022 Sep 23.
5
Tirzepatide Once Weekly for the Treatment of Obesity.司美格鲁肽每周一次治疗肥胖症。
N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4.
6
Patient Motivations and Goals for Bariatric Surgery: A Mixed Methods Study.患者接受减重手术的动机和目标:一项混合方法研究。
Surg Obes Relat Dis. 2021 Sep;17(9):1591-1602. doi: 10.1016/j.soard.2021.05.017. Epub 2021 May 17.
7
Case Report: Off Label Utilization of Topiramate and Metformin in Patients With BMI ≥50 kg/m Prior to Bariatric Surgery.病例报告:在接受减重手术前 BMI≥50kg/m²的患者中,托吡酯和二甲双胍的超适应证使用。
Front Endocrinol (Lausanne). 2021 Feb 25;12:588016. doi: 10.3389/fendo.2021.588016. eCollection 2021.
8
Once-Weekly Semaglutide in Adults with Overweight or Obesity.每周一次司美格鲁肽在超重或肥胖成人中的应用。
N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10.
9
Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009-2015.在 8 家大型医疗保健机构的 220 万成年人中使用抗肥胖药物:2009-2015 年。
Obesity (Silver Spring). 2019 Dec;27(12):1975-1981. doi: 10.1002/oby.22581. Epub 2019 Oct 11.
10
Patient motivations and expectations prior to bariatric surgery: A qualitative systematic review.患者在接受减重手术前的动机和期望:一项定性系统综述。
Obes Rev. 2019 Nov;20(11):1608-1618. doi: 10.1111/obr.12919. Epub 2019 Aug 16.